New Biotech Stock Gains Attention After $14 Billion Deal
You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here. This message is from Street Signals.
2024’s Biggest Investor Wins: Karuna’s $14 Billion Buyout Shakes Up Biotech What made it possible? It’s simple. Karuna Therapeutics created KarXT, a groundbreaking treatment aimed at schizophrenia, with additional potential for Alzheimer’s and bipolar disorder. Not long after, they were scooped up by Bristol Myers in a $14 billion deal. Today, we’re seeing a new company capturing the attention of savvy investors, potentially following in Karuna’s footsteps. With a recently awarded patent, this company is working on a groundbreaking replacement to marketed lithium therapies to treat similar diseases. Could this little-known biotech stock be the next big thing? Many experts think it just might be. >>Check Out 2024’s Hottest Biotech Deal Here Regards, Alzamend Neuro, Inc. |
Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431 We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security. We would like to inform you that we have received or expect to receive compensation in connection with the purchase or sale of the securities of Alzamend Neuro® , Inc (NASDAQ:ALZN). The compensation consists of up to $5,000 and was received/will be received from Market Jar Media. This compensation should not be considered as an endorsement of the securities of adviser Alzamend Neuro® , Inc (NASDAQ:ALZN) and we are not responsible for any errors or omissions in any information provided about the securities of Alzamend Neuro® , Inc (NASDAQ:ALZN) made by Street Signals or Alzamend Neuro, Inc. We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions. This disclosure is made as of 10/16/24 Behind the Markets
Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices.
Unsubscribeinvisiblelink
|
|
No comments:
Post a Comment